Share on StockTwits
 

Herbalife (NYSE:HLF)‘s stock had its “buy” rating reiterated by Canaccord Genuity in a research note issued on Tuesday, StockRatingsNetwork.com reports. They currently have a $87.00 target price on the stock, up from their previous target price of $77.00. Canaccord Genuity’s target price suggests a potential upside of 16.26% from the company’s current price.

Herbalife (NYSE:HLF) last announced its earnings results on Wednesday, October 30th. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.14 by $0.27. The company had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $1.20 billion. During the same quarter in the previous year, the company posted $1.04 earnings per share. The company’s revenue for the quarter was up 19.3% on a year-over-year basis.

A number of other analysts have also recently weighed in on HLF. Analysts at DA Davidson raised their price target on shares of Herbalife from $92.00 to $115.00 in a research note to investors on Tuesday. They now have a “buy” rating on the stock. Separately, analysts at SunTrust raised their price target on shares of Herbalife from $78.00 to $85.00 in a research note to investors on Tuesday. Finally, analysts at Wedbush raised their price target on shares of Herbalife from $76.00 to $81.00 in a research note to investors on Wednesday, October 30th. They now have an “outperform” rating on the stock. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Herbalife has a consensus rating of “Buy” and a consensus price target of $80.63.

Herbalife Ltd. is a global network marketing company that sells weight management, nutritional supplements, energy, sports and fitness products and personal care products through a network of approximately 2.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.